Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000060

Chief Medical Officer sold 4,189 shares at an average $17.46 ($73,130)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ho Carole · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-13 Sale : show line 1 in the form 10b5-1 −2,784 $17.29 $48,135 145,010 D
2024-02-14 Sale : show line 2 in the form 10b5-1 −1,405 $17.79 $24,995 143,605 D
Open-market sales · 4,189 sh · avg $17.46 · $73,130
Loading xslF345X05/wk-form4_1708049673.xml…